Dr. Kenneth Rivlin, MD
Claim this profileJacobi Medical Center
Studies Sickle Cell Anemia
Studies Sickle Cell Disease
5 reported clinical trials
4 drugs studied
Affiliated Hospitals
More about Kenneth Rivlin, MD
Clinical Trial Related5 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 0 Active Clinical TrialsTreatments Kenneth Rivlin, MD has experience with
- Crizanlizumab
- Placebo
- Inclacumab
- Voxelotor
Breakdown of trials Kenneth Rivlin, MD has run
Sickle Cell Anemia
Sickle Cell Disease
Sickle Cell Crisis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Kenneth Rivlin, MD specialize in?
Kenneth Rivlin, MD focuses on Sickle Cell Anemia and Sickle Cell Disease. In particular, much of their work with Sickle Cell Anemia has involved treating patients, or patients who are undergoing treatment.
Is Kenneth Rivlin, MD currently recruiting for clinical trials?
No, Kenneth Rivlin, MD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Kenneth Rivlin, MD has studied deeply?
Yes, Kenneth Rivlin, MD has studied treatments such as Crizanlizumab, Placebo, Inclacumab.
What is the best way to schedule an appointment with Kenneth Rivlin, MD?
Apply for one of the trials that Kenneth Rivlin, MD is conducting.
What is the office address of Kenneth Rivlin, MD?
The office of Kenneth Rivlin, MD is located at: Jacobi Medical Center, Bronx, New York 10461 United States. This is the address for their practice at the Jacobi Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.